Cross Country Healthcare (CCRN)

• Market cap: $578M
• 1 day: -0.06%
• 5 days: -0.56%
• 1 month: 75.42%
• 3 months: 23.26%
• 6 months: 24.46%
• Year to date: -23.20%
• 1 year: -18.55%
• 5 years: 55.33%
• 10 years: 45.97%
• Sector: Industrials
• Industry: Help Supply Services

About: Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Employees: 2,300

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

725% more call options, than puts

Call options by funds: $231K | Put options by funds: $28K

59% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 29

10% more funds holding

Funds holding: 162 [Q2] → 179 (+17) [Q3]

1.77% more ownership

Funds ownership: 100.85% [Q2] → 102.62% (+1.77%) [Q3]

5% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 57

3% less capital invested

Capital invested by funds: $485M [Q2] → $469M (-$15.8M) [Q3]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $18 1% upside
• Avg. target: $18.31 2% upside
• High target: $18.61 4% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

Truist Securities Tobey Sommer 43% 1-year accuracy 22 / 51 met price target	4% upside $18.61	Hold Maintained	5 Dec 2024
Benchmark Bill Sutherland 69% 1-year accuracy 33 / 48 met price target	1% upside $18	Buy Maintained	7 Nov 2024